Published in Lancet Neurol on August 01, 2013
Choline Alphoscerate-Nimodipine in Vascular Cognitive Impairment (CONIVAD) | NCT03228498
Cerebral small vessel disease and incident parkinsonism: The RUN DMC study. Neurology (2015) 3.23
The pathobiology of vascular dementia. Neuron (2013) 3.07
Outcome markers for clinical trials in cerebral amyloid angiopathy. Lancet Neurol (2014) 2.39
Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology (2014) 1.81
Cerebral amyloid angiopathy with and without hemorrhage: evidence for different disease phenotypes. Neurology (2015) 1.61
Association of Aortic Stiffness With Cognition and Brain Aging in Young and Middle-Aged Adults: The Framingham Third Generation Cohort Study. Hypertension (2016) 1.60
Strategic white matter tracts for processing speed deficits in age-related small vessel disease. Neurology (2014) 1.58
Small Brain Lesions and Incident Stroke and Mortality: A Cohort Study. Ann Intern Med (2015) 1.49
Enlarged perivascular spaces and small diffusion-weighted lesions in intracerebral hemorrhage. Neurology (2015) 1.42
Structural network efficiency predicts conversion to dementia. Neurology (2016) 1.41
Clinical effect of white matter network disruption related to amyloid and small vessel disease. Neurology (2015) 1.41
Subclinical cerebrovascular disease inversely associates with learning ability: The NOMAS. Neurology (2015) 1.38
Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord (2014) 1.21
What are white matter hyperintensities made of? Relevance to vascular cognitive impairment. J Am Heart Assoc (2015) 1.19
White matter perivascular spaces: an MRI marker in pathology-proven cerebral amyloid angiopathy? Neurology (2013) 1.18
The overlap between vascular disease and Alzheimer's disease--lessons from pathology. BMC Med (2014) 1.15
Individual variability of cerebral autoregulation, posterior cerebral circulation and white matter hyperintensity. J Physiol (2016) 1.11
Association between arterial stiffness, cerebral small vessel disease and cognitive impairment: A systematic review and meta-analysis. Neurosci Biobehav Rev (2015) 1.11
Vascular imaging abnormalities and cognition: mediation by cortical volume in nondemented individuals: atherosclerosis risk in communities-neurocognitive study. Stroke (2015) 1.07
White matter hyperintensities and normal-appearing white matter integrity in the aging brain. Neurobiol Aging (2014) 1.06
Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy. Brain (2014) 1.01
Regional white matter hyperintensities: aging, Alzheimer's disease risk, and cognitive function. Neurobiol Aging (2013) 1.00
Post-mortem assessment in vascular dementia: advances and aspirations. BMC Med (2016) 0.98
Cerebral perivascular spaces visible on magnetic resonance imaging: development of a qualitative rating scale and its observer reliability. Cerebrovasc Dis (2015) 0.97
Blood pressure, internal carotid artery flow parameters, and age-related white matter hyperintensities. Hypertension (2014) 0.97
Vascular parkinsonism--characteristics, pathogenesis and treatment. Nat Rev Neurol (2015) 0.97
Early cerebral small vessel disease and brain volume, cognition, and gait. Ann Neurol (2015) 0.96
Multimodal markers of inflammation in the subcortical ischemic vascular disease type of vascular cognitive impairment. Stroke (2014) 0.96
Deep multi-scale location-aware 3D convolutional neural networks for automated detection of lacunes of presumed vascular origin. Neuroimage Clin (2017) 0.94
White matter hyperintensities in middle-aged adults with childhood-onset type 1 diabetes. Neurology (2015) 0.92
Stroke genetics: a review and update. J Stroke (2014) 0.91
Structural imaging measures of brain aging. Neuropsychol Rev (2014) 0.91
Ischemic brain injury in cerebral amyloid angiopathy. J Cereb Blood Flow Metab (2016) 0.89
Silent cerebral infarcts associated with cardiac disease and procedures. Nat Rev Cardiol (2013) 0.89
Acute infarcts cause focal thinning in remote cortex via degeneration of connecting fiber tracts. Neurology (2015) 0.89
White matter lesion load is associated with resting state functional MRI activity and amyloid PET but not FDG in mild cognitive impairment and early Alzheimer's disease patients. J Magn Reson Imaging (2013) 0.89
Microinfarct disruption of white matter structure: a longitudinal diffusion tensor analysis. Neurology (2014) 0.89
An algorithmic approach to structural imaging in dementia. J Neurol Neurosurg Psychiatry (2013) 0.89
Automatic Detection of White Matter Hyperintensities in Healthy Aging and Pathology Using Magnetic Resonance Imaging: A Review. Neuroinformatics (2015) 0.88
Retinal microvascular abnormalities predict progression of brain microvascular disease: an atherosclerosis risk in communities magnetic resonance imaging study. Stroke (2014) 0.88
Hyperactivation of working memory-related brain circuits in newly diagnosed middle-aged type 2 diabetics. Acta Diabetol (2014) 0.88
Silent Brain Infarction and Risk of Future Stroke: A Systematic Review and Meta-Analysis. Stroke (2016) 0.87
Cortical thickness estimation in longitudinal stroke studies: A comparison of 3 measurement methods. Neuroimage Clin (2014) 0.87
Evolving Concept of Small Vessel Disease through Advanced Brain Imaging. J Stroke (2015) 0.87
Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions. Int J Stroke (2015) 0.87
Impact of nocturnal heart rate variability on cerebral small-vessel disease progression: a longitudinal study in community-dwelling elderly Japanese. Hypertens Res (2015) 0.87
Cardiovascular risk factors and small vessel disease of the brain: Blood pressure, white matter lesions, and functional decline in older persons. J Cereb Blood Flow Metab (2016) 0.87
Long-Term Blood-Brain Barrier Permeability Changes in Binswanger Disease. Stroke (2015) 0.87
Early white matter changes in CADASIL: evidence of segmental intramyelinic oedema in a pre-clinical mouse model. Acta Neuropathol Commun (2014) 0.86
Prognostic Impact of Cerebral Small Vessel Disease on Stroke Outcome. J Stroke (2015) 0.86
Prevalence of cortical superficial siderosis in patients with cognitive impairment. J Neurol (2013) 0.86
Cerebral small vessel disease and renal function: systematic review and meta-analysis. Cerebrovasc Dis (2014) 0.85
Reduced blood flow in normal white matter predicts development of leukoaraiosis. J Cereb Blood Flow Metab (2015) 0.85
Hemodynamic factors may play a critical role in neurological deterioration occurring within 72 hrs after lacunar stroke. PLoS One (2014) 0.85
Current pathophysiological concepts in cerebral small vessel disease. Front Aging Neurosci (2014) 0.85
White matter hyperintensity patterns in cerebral amyloid angiopathy and hypertensive arteriopathy. Neurology (2016) 0.85
A comparison of location of acute symptomatic vs. 'silent' small vessel lesions. Int J Stroke (2015) 0.84
Imaging the Perivascular Space as a Potential Biomarker of Neurovascular and Neurodegenerative Diseases. Cell Mol Neurobiol (2016) 0.84
Association of arterial stiffness with progression of subclinical brain and cognitive disease. Neurology (2016) 0.84
Strategic lacunes and their relationship to cognitive impairment in cerebral small vessel disease. Neuroimage Clin (2014) 0.84
Fate of diffusion restricted lesions in acute intracerebral hemorrhage. PLoS One (2014) 0.84
Brain volumetric changes and cognitive ageing during the eighth decade of life. Hum Brain Mapp (2015) 0.84
Integrity of normal-appearing white matter: Influence of age, visible lesion burden and hypertension in patients with small-vessel disease. J Cereb Blood Flow Metab (2016) 0.84
Executive function changes before memory in preclinical Alzheimer's pathology: a prospective, cross-sectional, case control study. PLoS One (2013) 0.84
The spectrum of MR detectable cortical microinfarcts: a classification study with 7-tesla postmortem MRI and histopathology. J Cereb Blood Flow Metab (2015) 0.84
Consensus statement for diagnosis of subcortical small vessel disease. J Cereb Blood Flow Metab (2016) 0.84
Non-invasive imaging of oxygen extraction fraction in adults with sickle cell anaemia. Brain (2016) 0.84
Cerebral autoregulation, beta amyloid, and white matter hyperintensities are interrelated. Neurosci Lett (2015) 0.83
Cerebral amyloid angiopathy severity is linked to dilation of juxtacortical perivascular spaces. J Cereb Blood Flow Metab (2015) 0.83
The APOE4 allele shows opposite sex bias in microbleeds and Alzheimer's disease of humans and mice. Neurobiol Aging (2015) 0.83
Primary Open Angle Glaucoma is Associated with MR Biomarkers of Cerebral Small Vessel Disease. Sci Rep (2016) 0.83
Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: A review. J Cereb Blood Flow Metab (2016) 0.83
Progression of MRI markers in cerebral small vessel disease: Sample size considerations for clinical trials. J Cereb Blood Flow Metab (2016) 0.82
Tracer kinetic modelling for DCE-MRI quantification of subtle blood-brain barrier permeability. Neuroimage (2015) 0.82
In vivo high-resolution 7 Tesla MRI shows early and diffuse cortical alterations in CADASIL. PLoS One (2014) 0.82
Cerebral small vessel disease: Capillary pathways to stroke and cognitive decline. J Cereb Blood Flow Metab (2015) 0.82
Recommendations from the international stroke genetics consortium, part 1: standardized phenotypic data collection. Stroke (2014) 0.82
Virchow-Robin Spaces: Correlations with Polysomnography-Derived Sleep Parameters. Sleep (2015) 0.82
Imaging in StrokeNet: Realizing the Potential of Big Data. Stroke (2015) 0.82
Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease. Nat Rev Neurosci (2017) 0.82
Rationale, design and methodology of the image analysis protocol for studies of patients with cerebral small vessel disease and mild stroke. Brain Behav (2015) 0.82
Development and initial evaluation of a semi-automatic approach to assess perivascular spaces on conventional magnetic resonance images. J Neurosci Methods (2015) 0.81
Cerebral Small Vessel Disease and Arterial Stiffness: Tsunami Effect in the Brain? Pulse (Basel) (2016) 0.81
Pattern and Rate of Cognitive Decline in Cerebral Small Vessel Disease: A Prospective Study. PLoS One (2015) 0.81
Apolipoprotein E and Sex Bias in Cerebrovascular Aging of Men and Mice. Trends Neurosci (2016) 0.81
Capillary dysfunction: its detection and causative role in dementias and stroke. Curr Neurol Neurosci Rep (2015) 0.81
Central artery stiffness, baroreflex sensitivity, and brain white matter neuronal fiber integrity in older adults. Neuroimage (2015) 0.81
Apolipoprotein E-dependent load of white matter hyperintensities in Alzheimer's disease: a voxel-based lesion mapping study. Alzheimers Res Ther (2015) 0.81
Genetic factors in cerebral small vessel disease and their impact on stroke and dementia. J Cereb Blood Flow Metab (2016) 0.81
Thyroid-stimulating hormone, white matter hyperintensities, and functional outcome in acute ischemic stroke patients. Cerebrovasc Dis Extra (2014) 0.81
Imaging of acute stroke prior to treatment: current practice and evolving techniques. Br J Radiol (2014) 0.81
Cerebral small vessel disease, cognitive reserve and cognitive dysfunction. J Neurol (2015) 0.81
Arterial ischemic stroke in HIV: Defining and classifying etiology for research studies. Neurol Neuroimmunol Neuroinflamm (2016) 0.81
White matter integrity in small vessel disease is related to cognition. Neuroimage Clin (2015) 0.81
Subcortical hyperintensity volumetrics in Alzheimer's disease and normal elderly in the Sunnybrook Dementia Study: correlations with atrophy, executive function, mental processing speed, and verbal memory. Alzheimers Res Ther (2014) 0.81
Clinical Outcome in Acute Ischemic Stroke Patients With Microbleeds After Thrombolytic Therapy: A Meta-Analysis. Medicine (Baltimore) (2015) 0.81
White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters. Neurobiol Aging (2015) 0.81
Cortical Superficial Siderosis in Memory Clinic Patients: Further Evidence for Underlying Cerebral Amyloid Angiopathy. Cerebrovasc Dis (2016) 0.80
Imaging small vessel-associated white matter changes in aging. Neuroscience (2013) 0.80
Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA (1997) 10.75
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology (2007) 9.27
Spontaneous intracerebral hemorrhage. N Engl J Med (2001) 8.60
The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ (2010) 7.93
Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke (1996) 7.81
National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke (2006) 6.94
Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology (2001) 6.42
Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol (2009) 6.02
A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke (2001) 5.81
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol (2010) 5.76
Silent brain infarcts: a systematic review. Lancet Neurol (2007) 5.76
Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ (2001) 5.40
Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke (2004) 4.56
Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology (2008) 3.76
Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol (1999) 3.67
The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease. Neuroscience (2000) 3.40
Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology (2010) 3.31
Computer-assisted imaging to assess brain structure in healthy and diseased brains. Lancet Neurol (2003) 3.26
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement (2011) 3.05
Superficial siderosis. Neurology (2006) 2.98
Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain (2007) 2.93
Leuko-araiosis. Arch Neurol (1987) 2.93
Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. Arch Neurol (1998) 2.77
Neuropathological basis of magnetic resonance images in aging and dementia. Ann Neurol (2008) 2.71
Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry (2010) 2.44
Cerebral microinfarcts: the invisible lesions. Lancet Neurol (2012) 2.31
Development and initial testing of normal reference MR images for the brain at ages 65-70 and 75-80 years. Eur Radiol (2008) 2.26
Incident subcortical infarcts induce focal thinning in connected cortical regions. Neurology (2012) 2.23
Understanding white matter disease: imaging-pathological correlations in vascular cognitive impairment. Stroke (2008) 2.21
The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds. Neurology (2009) 2.14
Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease. Stroke (2010) 2.14
MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease. Neurology (2001) 2.11
Enlarged perivascular spaces are associated with cognitive function in healthy elderly men. J Neurol Neurosurg Psychiatry (2004) 2.11
Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke (2003) 2.10
improving interrater agreement about brain microbleeds: development of the Brain Observer MicroBleed Scale (BOMBS). Stroke (2008) 2.09
Comparison of 7.0-T T₂*-magnetic resonance imaging of cerebral bleeds in post-mortem brain sections of Alzheimer patients with their neuropathological correlates. Cerebrovasc Dis (2011) 2.05
Distinguishing silent lacunar infarction from enlarged Virchow-Robin spaces: a magnetic resonance imaging and pathological study. J Neurol (1998) 2.02
Virchow-Robin spaces at MR imaging. Radiographics (2007) 2.01
Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations. Stroke (1987) 1.96
Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative. Arch Neurol (2010) 1.94
Severity of dilated Virchow-Robin spaces is associated with age, blood pressure, and MRI markers of small vessel disease: a population-based study. Stroke (2010) 1.91
Cerebral microbleeds in CADASIL: a gradient-echo magnetic resonance imaging and autopsy study. Stroke (2002) 1.88
CT and MRI rating of white matter lesions. Cerebrovasc Dis (2002) 1.83
Visual rating of age-related white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurements. Stroke (2003) 1.78
New multispectral MRI data fusion technique for white matter lesion segmentation: method and comparison with thresholding in FLAIR images. Eur Radiol (2010) 1.76
A new visual rating scale to assess strategic white matter hyperintensities within cholinergic pathways in dementia. Stroke (2005) 1.74
Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study. PLoS Med (2009) 1.72
New ischemic lesions coexisting with acute intracerebral hemorrhage. Neurology (2012) 1.67
A systematic review of the utility of 1.5 versus 3 Tesla magnetic resonance brain imaging in clinical practice and research. Eur Radiol (2012) 1.64
Mechanisms of acute cerebral infarctions in patients with middle cerebral artery stenosis: a diffusion-weighted imaging and microemboli monitoring study. Ann Neurol (2002) 1.64
Cerebral microbleeds: histopathological correlation of neuroimaging. Cerebrovasc Dis (2011) 1.63
Loss of white matter integrity is associated with gait disorders in cerebral small vessel disease. Brain (2010) 1.58
Perivascular spaces in the basal ganglia of the human brain: their relationship to lacunes. J Anat (1997) 1.56
Silent stroke: not listened to rather than silent. Stroke (2012) 1.56
Virchow-Robin spaces relate to cerebral small vessel disease severity. J Neurol (2008) 1.56
Large Virchow-Robin spaces: MR-clinical correlation. AJNR Am J Neuroradiol (1989) 1.53
Neuropathological correlates of dementia in over-80-year-old brain donors from the population-based Cambridge city over-75s cohort (CC75C) study. J Alzheimers Dis (2009) 1.53
In vivo detection of cerebral cortical microinfarcts with high-resolution 7T MRI. J Cereb Blood Flow Metab (2012) 1.49
Cerebral microinfarcts: a systematic review of neuropathological studies. J Cereb Blood Flow Metab (2012) 1.47
Measuring progression of cerebral white matter lesions on MRI: visual rating and volumetrics. Neurology (2004) 1.46
Stress-related primary intracerebral hemorrhage: autopsy clues to underlying mechanism. Stroke (2000) 1.44
Dilatation of the Virchow-Robin space is a sensitive indicator of cerebral microvascular disease: study in elderly patients with dementia. AJNR Am J Neuroradiol (2005) 1.40
Brain MR: pathologic correlation with gross and histopathology. 2. Hyperintense white-matter foci in the elderly. AJR Am J Roentgenol (1988) 1.39
Virchow-Robin spaces on magnetic resonance images: normative data, their dilatation, and a review of the literature. Neuroradiology (2006) 1.37
Qualitative assessment of cerebral atrophy on MRI: inter- and intra-observer reproducibility in dementia and normal aging. Eur Neurol (1997) 1.36
The stroke syndrome of striatocapsular infarction. Brain (1991) 1.34
Harmonization of magnetic resonance-based manual hippocampal segmentation: a mandatory step for wide clinical use. Alzheimers Dement (2011) 1.34
Haemodialysis and cerebral oedema. Nephron (2001) 1.33
Dehydration confounds the assessment of brain atrophy. Neurology (2005) 1.30
Counting cavitating lacunes underestimates the burden of lacunar infarction. Stroke (2009) 1.27
Frequency and location of dilated Virchow-Robin spaces in elderly people: a population-based 3D MR imaging study. AJNR Am J Neuroradiol (2011) 1.23
Close correlation between quantitative and qualitative assessments of white matter lesions. Neuroepidemiology (2012) 1.22
Is hypertension a more frequent risk factor for deep than for lobar supratentorial intracerebral haemorrhage? J Neurol Neurosurg Psychiatry (2006) 1.19
Lesion Explorer: a comprehensive segmentation and parcellation package to obtain regional volumetrics for subcortical hyperintensities and intracranial tissue. Neuroimage (2010) 1.19
Direct comparison of histology of microbleeds with postmortem MR images: a case report. Cerebrovasc Dis (2008) 1.18
Cavitation after acute symptomatic lacunar stroke depends on time, location, and MRI sequence. Stroke (2012) 1.16
Wide variation in definition, detection, and description of lacunar lesions on imaging. Stroke (2010) 1.15
White matter lesions and brain atrophy: more than shared risk factors? A systematic review. Cerebrovasc Dis (2009) 1.11
Characteristics of patients with minor ischaemic strokes and negative MRI: a cross-sectional study. J Neurol Neurosurg Psychiatry (2010) 1.11
Cerebral lacunae. A proposed new classification. Clin Neuropathol (1985) 1.11
Changes in DWI and MRS associated with white matter hyperintensities in elderly subjects. Neurology (2003) 1.11
Measuring longitudinal white matter changes: comparison of a visual rating scale with a volumetric measurement. AJNR Am J Neuroradiol (2006) 1.08
How much do focal infarcts distort white matter lesions and global cerebral atrophy measures?. Cerebrovasc Dis (2012) 1.08
Covert neurological symptoms associated with silent infarcts from midlife to older age: the Atherosclerosis Risk in Communities study. Stroke (2012) 1.08
Silent brain infarcts: a review of MRI diagnostic criteria. Stroke (2011) 1.08
A comparison of MR based segmentation methods for measuring brain atrophy progression. Neuroimage (2010) 1.05
Brain atrophy associations with white matter lesions in the ageing brain: the Lothian Birth Cohort 1936. Eur Radiol (2012) 1.05
Semiautomated detection of cerebral microbleeds in magnetic resonance images. Magn Reson Imaging (2011) 1.04
Microbleed detection using automated segmentation (MIDAS): a new method applicable to standard clinical MR images. PLoS One (2011) 1.03
Differential impact of lacunes and microvascular lesions on poststroke depression. Stroke (2009) 1.03
Are multiple acute small subcortical infarctions caused by embolic mechanisms? J Neurol Neurosurg Psychiatry (2004) 1.02
Subjective cognitive complaints relate to white matter hyperintensities and future cognitive decline in patients with cardiovascular disease. Am J Geriatr Psychiatry (2009) 1.00
Lacunar infarcts: no black holes in the brain are benign. Pract Neurol (2008) 1.00
Associations of clinical stroke misclassification ('clinical-imaging dissociation') in acute ischemic stroke. Cerebrovasc Dis (2010) 0.99
Alliance for aging research AD biomarkers work group: structural MRI. Neurobiol Aging (2011) 0.98
Silent infarcts and cerebral microbleeds modify the associations of white matter lesions with gait and postural stability: population-based study. Stroke (2012) 0.97
Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 143.19
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Global prevalence of dementia: a Delphi consensus study. Lancet (2005) 23.30
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 21.80
Priority actions for the non-communicable disease crisis. Lancet (2011) 15.18
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15
The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging (2008) 14.68
Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med (2012) 14.14
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med (2010) 13.82
Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med (2015) 12.70
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet (2010) 11.00
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain (2011) 9.90
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol (2010) 8.74
The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord (2006) 8.04
Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature (2007) 8.03
Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial. Lancet (2015) 7.16
Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol (2006) 6.97
National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke (2006) 6.94
Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med (2014) 6.73
Automatic classification of MR scans in Alzheimer's disease. Brain (2008) 6.71
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. N Engl J Med (2014) 6.50
Age, neuropathology, and dementia. N Engl J Med (2009) 6.36
UK health performance: findings of the Global Burden of Disease Study 2010. Lancet (2013) 6.11
Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol (2009) 6.02
MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol (2012) 5.91
Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med (2012) 5.69
Alzheimer's disease. Lancet (2011) 5.35
Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med (2006) 5.20
Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA (2013) 5.05
11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study. Lancet Neurol (2010) 5.03
Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan: Response. Radiology (2017) 4.99
The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol (2010) 4.59
Weekends: a dangerous time for having a stroke? Stroke (2007) 4.47
The fugl-meyer assessment of motor recovery after stroke: a critical review of its measurement properties. Neurorehabil Neural Repair (2002) 4.47
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol (2013) 4.29
Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study. Lancet Neurol (2006) 4.19
Epidemiology of Alzheimer disease. Nat Rev Neurol (2011) 4.13
A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke. Nat Genet (2009) 4.11
Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: an fMRI study. Hum Brain Mapp (2005) 4.11
Donepezil for the treatment of agitation in Alzheimer's disease. N Engl J Med (2007) 4.11
Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci U S A (2002) 4.07
PML in a patient treated with dimethyl fumarate from a compounding pharmacy. N Engl J Med (2013) 4.02
Get With the Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack. Circulation (2008) 4.00
Prevalence of autism-spectrum conditions: UK school-based population study. Br J Psychiatry (2009) 3.97
Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet (2008) 3.93
Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol (2012) 3.93
Political drive to screen for pre-dementia: not evidence based and ignores the harms of diagnosis. BMJ (2013) 3.93
Cadasil. Lancet Neurol (2009) 3.88
Longitudinal stability of MRI for mapping brain change using tensor-based morphometry. Neuroimage (2006) 3.85
Long-term mortality after stroke among adults aged 18 to 50 years. JAMA (2013) 3.84
Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol (2009) 3.82
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial. Lancet (2011) 3.76
Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke. Ann Neurol (2008) 3.75
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
Vascular cognitive impairment. Lancet Neurol (2003) 3.73
Meningiomas. Lancet (2004) 3.69
Early dual versus mono antiplatelet therapy for acute non-cardioembolic ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis. Circulation (2013) 3.57
MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol (2007) 3.47
Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol (2010) 3.47
A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch Neurol (2003) 3.44
Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial. Lancet Neurol (2009) 3.42
Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet (2012) 3.40
Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet (2011) 3.40
Orphan CpG islands identify numerous conserved promoters in the mammalian genome. PLoS Genet (2010) 3.38
Subcortical ischaemic vascular dementia. Lancet Neurol (2002) 3.32
Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation (2011) 3.30
White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke (2006) 3.27
Computer-assisted imaging to assess brain structure in healthy and diseased brains. Lancet Neurol (2003) 3.26
Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. Lancet Neurol (2007) 3.22
Fast free-form deformation using graphics processing units. Comput Methods Programs Biomed (2009) 3.18
Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study. Lancet Neurol (2011) 3.16
Distinguishing between stroke and mimic at the bedside: the brain attack study. Stroke (2006) 3.12
Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator. JAMA (2012) 3.07
Automatic differentiation of anatomical patterns in the human brain: validation with studies of degenerative dementias. Neuroimage (2002) 3.06
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement (2011) 3.05
Visceral fat is associated with lower brain volume in healthy middle-aged adults. Ann Neurol (2010) 3.05
Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up. BMJ (2008) 3.03
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain (2009) 3.03